Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 8, 2021

Piroxicam reduces acute and chronic pain response in type 1 diabetic rats

  • Abbas Alimoradian , Fatemeh Samimi , Hadise Aslfalah , Seied Amirhossein Latifi , Mehdi Salehi , Maryam Khodaei and Jamal Amri EMAIL logo

Abstract

Objectives

Pain associated with various underlying pathologies is a major cause of morbidity and diminished life quality in diabetic patients. Effective control of pain requires the use of analgesics with the best efficacy and with minimal side effects. Therefore, our aim in this study was to investigate the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on pain in diabetic rats.

Methods

In this study, we investigated the analgesic effects of drugs belonging to three different classes of NSAIDs in a rat model of diabetes. Four diabetic groups received normal saline, diclofenac, piroxicam and ketorolac, respectively, and four non-diabetic groups received normal saline, diclofenac, piroxicam and ketorolac. Type 1 diabetes was induced in rats by a single injection of streptozotocin (60 mg/kg bw). Formalin (50 µL of 2.5%) nociception assay was used to examine the effect of treatment with diclofenac, piroxicam and ketorolac on acute and chronic pain in healthy and diabetic rats.

Results

Piroxicam showed significant analgesic effects both in the acute phase of pain (5–10 min after injection of formalin into the left hind paw), and in the chronic phase (20–60 min after formalin injection) in healthy as well as diabetic rats. Diclofenac and ketorolac also reduced pain scores in healthy rats. However, these two drugs failed to diminish pain in diabetic rats.

Conclusion

Our data point for better efficacy of piroxicam in controlling pain in diabetes.


Corresponding author: Jamal Amri, Member, Traditional and Complementary Medicine Research Center, Faculty of Medicine, Arak University of Medical Sciences, Arak 3848176941, Iran; and Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, E-mail:

Funding source: Arak University of Medical Sciences

Acknowledgments

The authors would like to thank the Arak University of Medical Sciences, Arak, Iran for financial support.

  1. Research funding: This work was supported by funds from the Arak University of Medical Sciences (Grant number: 1033).

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

  4. Ethical approval: The present study was approved by Review Board and Ethics Committee of Arak University of Medical Sciences, Iran.

References

1. Alimoradian, A, Ghasemi, S, Zahiri, M, Saeedi, AH, Miladi, H, Sadegh, M. Investigation of the effect of Ginkgo biloba leaf extract on spatial memory impairment and hippocampal neuronal loss caused by diabetes induced by streptozotocin in rats. SJKUMS 2018;23:11–23. https://doi.org/10.29252/sjku.23.2.114.Search in Google Scholar

2. Singh, R, Kishore, L, Kaur, N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol Res 2014;80:21–35. https://doi.org/10.1016/j.phrs.2013.12.005.Search in Google Scholar

3. Peltier, A, Goutman, SA, Callaghan, BC. Painful diabetic neuropathy. BMJ 2014;348:g1799. https://doi.org/10.1136/bmj.g1799.Search in Google Scholar

4. Schreiber, AK, Nones, CF, Reis, RC, Chichorro, JG, Cunha, JM. Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 2015;6:432–44. https://doi.org/10.4239/wjd.v6.i3.432.Search in Google Scholar

5. Tajti, J, Szok, D, Majlath, Z, Csati, A, Petrovics-Balog, A, Vecsei, L. Alleviation of pain in painful diabetic neuropathy. Expert Opin Drug Metab Toxicol 2016;12:753–64. https://doi.org/10.1080/17425255.2016.1184648.Search in Google Scholar

6. Lee, YC, Chen, PP. A review of SSRIs and SNRIs in neuropathic pain. Expert Opin Pharmacother 2010;11:2813–25. https://doi.org/10.1517/14656566.2010.507192.Search in Google Scholar

7. Dubuisson, D, Dennis, SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977;4:161–74. https://doi.org/10.1016/0304-3959(77)90130-0.Search in Google Scholar

8. Mokhtari, M, Shariati, M, Rezaeian, MS. Effects of L-NAME on antinociceptive induced by morphine in formalin test. AJAVA 2007;2:15–20.10.3923/ajava.2007.15.20Search in Google Scholar

9. Woller, SA, Eddinger, KA, Corr, M, Yaksh, TL. An overview of pathways encoding nociception. Clin Exp Rheumatol 2017;35:40–6.Search in Google Scholar

10. Comi, G, Corbo, M. Metabolic neuropathies. Curr Opin Neurol 1998;11:523–9. https://doi.org/10.1097/00019052-199810000-00015.Search in Google Scholar PubMed

11. Noshinfar, E, Hamidpoor, M, Akbarzadeh - Baghban, AR, Mansoori, V, Salahi Yekta, A, Heidari, MH, et al.. The effect of diabetes persistence on formalin-induced pain and baclofen-induced analgesia in rats. Pajoohande 2003;8:9–15.Search in Google Scholar

12. Oguntibeju, OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol 2019;11:45–63.Search in Google Scholar

13. Giri, B, Dey, S, Das, T, Sarkar, M, Banerjee, J, Dash, SK. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed Pharmacother 2018;107:306–28. https://doi.org/10.1016/j.biopha.2018.07.157.Search in Google Scholar PubMed

14. Cashman, JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996;52:13–23. https://doi.org/10.2165/00003495-199600525-00004.Search in Google Scholar PubMed

15. Hossein Zadeh, H, Ilami, F. Antinociceptive effect of baclofen in alloxan-induced diabetic mice. J Diabetes Investig 2001;1:51–7.Search in Google Scholar

16. Parry, GJ, Kozu, H. Piroxicam may reduce the rate of progression of experimental diabetic neuropathy. Neurology 1990;40:1446–9. https://doi.org/10.1212/wnl.40.9.1446.Search in Google Scholar PubMed

17. O’Hanlon, JJ, Beers, H, Huss, BK, Milligan, KR. A comparison of the effect of intramuscular diclofenac, ketorolac or piroxicam on postoperative pain following laparoscopy. Ulster Med J 1996;65:51–4.Search in Google Scholar

Received: 2019-12-21
Accepted: 2020-09-10
Published Online: 2021-02-08

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 4.5.2024 from https://www.degruyter.com/document/doi/10.1515/jbcpp-2019-0367/html
Scroll to top button